Ultimovacs ASA (Norway) Overlap Studies Exponential Moving Average
| ULTI Stock | NOK 2.07 0.02 0.98% |
| Symbol |
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Exponential Moving Average is calculated by weighting recent values of Ultimovacs ASA more heavily than older values.
Ultimovacs ASA Technical Analysis Modules
Most technical analysis of Ultimovacs ASA help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ultimovacs from various momentum indicators to cycle indicators. When you analyze Ultimovacs charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ultimovacs ASA Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ultimovacs ASA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ultimovacs ASA based on widely used predictive technical indicators. In general, we focus on analyzing Ultimovacs Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ultimovacs ASA's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Ultimovacs ASA's intrinsic value. In addition to deriving basic predictive indicators for Ultimovacs ASA, we also check how macroeconomic factors affect Ultimovacs ASA price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Become your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | Hedge Favorites Invested over 40 shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
 | Investor Favorites Invested few shares | |
 | Chemicals Invested over 30 shares | |
 | Business Services Invested over 100 shares | |
 | Adviser Favorites Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | FinTech Invested over 40 shares |
Other Information on Investing in Ultimovacs Stock
Ultimovacs ASA financial ratios help investors to determine whether Ultimovacs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ultimovacs with respect to the benefits of owning Ultimovacs ASA security.